. We present here the main characteristics of seven tumour cell lines derived from patients diagnosed and treated for ovarian cancer. Recent information obtained from DNA fingerprinting and karyotyping has shown that an eighth cell line is identical with one of the cell lines described here (OAW 28 = 41M); this information is documented because OAW 28 and 41M have been distributed previously as two separate cell lines and phenotypic differences have been reported (Hills et al., 1989) . One of the cell lines (OAW 42) has been described elsewhere (Wilson, 1984; Hill et al., 1984) , and four of them (OAW 42, OAW 28, 41M and 59M) have been used in a panel of ten lines investigated for response to platinum complexes (Hills et al., 1989 ). Characteristics which are described include morphology, ultrastructure, karyotype and expression of OC125, HMFG2, vimentin, pan-keratin and keratin-7.
In spite of the higher response rates which can be achieved using platinum-based chemotherapy for the treatment of ovarian cancer, 5 year survival rates remain low for advanced disease, and ovarian cancer continues to represent a major clinical challenge. The failure of current treatment regimes to increase survival times reflects the fact that our knowledge of the biology of ovarian cancer has not yet produced information which has had a major impact on therapy and perhaps indicates that improvement in cure rates can only be expected when the biology of the disease is more clearly understood. Ovarian cancer is a heterogeneous disease even within tumours of the same histological type, and a range of lines with a well-documented history and detailed characterisation is therefore useful for exploring this heterogeneity at the cellular level. The literature contains descriptions of 70 ovarian tumour cell lines, the majority representing reports of only one or two lines. Four groups describe a series containing five or more lines (Simon et al., 1983; Langdon et al., 1988; Mobus et al., 1992; Ishiwata et al., 1986 Ishiwata et al., , 1987a Ishiwata et al., ,b 1988 . We present here the main characteristics of seven tumour cell lines derived from patients diagnosed and treated for ovarian cancer. Recent information obtained from DNA fingerprinting and karyotyping has shown that an eighth cell line is identical with one of the cell lines described here (OAW 28 = 41M); this information is documented because OAW 28 and 41M have been distributed previously as two separate cell lines and phenotypic differences have been reported (Hills et al., 1989) . One of the cell lines (OAW 42) has been described elsewhere (Wilson, 1984; Hill et al., 1984) , and four of them (OAW 42, OAW 28, 41M and 59M) have been used in a panel of ten lines investigated for response to platinum complexes (Hills et al., 1989 ). Characteristics which are described include morphology, ultrastructure, karyotype and expression of OC125, HMFG2, vimentin, pan-keratin and keratin-7.
Materials and methods
Seven cell lines developed from ascites (6) and tumour tissue (1) from seven patients with proven or suspected ovarian carcinoma are described here. Patient histories for each line are as follows:
OA W 42 A detailed history has been described elsewhere (Wilson, 1984) . Briefly, the cell line was derived from an ascitic fluid sample of a 46-year-old patient in relapse after a complete response to six courses of 100 mg m-2 cis-platinum. Histologically, the tumour was a papillary serous cystadenocarcinoma. The patient died 1 month after paracentesis.
OA W 28 The cell line was derived from the ascites of a 75-year-old patient who had been treated with cis-platinum and melphalan, without response. The patient died 3 days after paracentesis. The tumour was described as an adenocarcinoma of the ovary.
59M
The 65-year-old patient had previously presented with stage IA carcinoma of the ovary together with in situ carcinoma of the endometrium and tubes as separate primaries. After laparotomy she was followed up without further treatment but presented 2 years later with ascites and a lump in the breast which was diagnosed as metastatic ovarian cancer. The cell line was established from the ascitic fluid sample. Following paracentesis, the patient was treated with ifosulphamide and melphalan and although she showed some response, treatment had to be discontinued owing to toxicity. The patient died 10 months after paracentesis. Histologically, the tumour was described as an endometroid carcinoma with clear cell areas.
138D
The 53-year-old patient had been treated with six courses of carboplatin following laparotomy for bilateral serous cystadenocarcinoma of the ovary, but she relapsed 7 months after the operation. The cell line was established from an ascitic fluid sample taken at relapse. Palliative chemotherapy with melphalan was commenced but the patient died 2 months later.
180D
The cell line established from the ascites of a 53-yearold patient taken during laparotomy after relapse. Initial diagnosis of carcinoma of the ovary had been made at laparotomy 2 years previously when a bilateral salpingooophorectomy and omentectomy was performed but the uterus was left in situ because of bulky disease. The patient then received six courses of cis-platinum. The uterus was removed 10 months later and found to contain an adenocarcinoma of the endometrium which had invaded but not completely penetrated the myometrium. Further chemotherapy with six courses of carboplatin was then given and another laparotomy was performed on completion. The abdominal cavity was found to contain ascites (180D) and there was a solid tumour deposit on the bowel. Although histologically the tumour was described as a metastatic papillary adenocarcinoma of ovarian origin, the possibility of a bowel primary could not be excluded. (FCS) and streptomycin, buffered with 3.7 g 1-1 of sodium bicarbonate). The solid tumour, from which 200D was established, was very soft and was mechanically disaggregated without enzyme treatment. Cells were resuspended at -2 -5 x 105 viable cells ml-' and added to plastic tissue culture flasks (Nunc) which were incubated at 37°C in an atmosphere of 95% air/5% carbon dioxide. Stromal cell contamination was a problem with 138D and 180D, and this was eliminated by a combination of differential enzyme treatment and exposure to fibrin. Briefly, monolayers of mixed cell cultures were incubated overnight in a cell-free ascitic fluid known to produce a fibrin mesh on exposure to cells (Wilson, 1987) . The mesothelial cells but not the epithelial cells attached to the fibrin, and it was found that a short exposure to trypsin-versene produced complete detachment of the mesothelial cell sheet attached to the fibrin mesh without removing epithelial islands (Figure 1 Doubling times Cells were added at 2 x 104 ml-' in 10 ml volumes to 25 cm2 flasks and cell numbers determined by harvesting and counting triplicate flasks over a period of -10 days, using the standard growth medium for each cell line. Clonogenicity in soft agar Bases of 1 ml of the standard growth medium in 0.5% agar were prepared in 35 mm Petri dishes and cells added as a single cell suspension in a 1 ml overlay containing 0.3% agar. Plates were checked microscopically to confirm that no clumps were present and that agar was solidified. Seven cell concentrations were used, starting at 5 x 105 ml-' and decreasing in doubling dilutions. After 10-14 days incubaa h tion at 37°C in a humidified atmosphere containing 5% carbon dioxide, colonies (>50 pm) were counted using an inverted microscope at x 100 magnification.
Cytogenetic methods For cytogenetic analysis cells were passed onto glass-chamber slides and cultured for 24-48 h in an appropriate medium. After exposure to colcemid (0.02 pg ml-1), the cultures were In the subsequent cytogenetic analysis, the same structural rearrangement or extra chromosome had to be found in at least two cells, monosomies in at least three mitoses, to be accepted as clonal. The karyotypes were described in accordance with the recommendations of the ISCN (1991). Ultrastructure Confluent cell monolayers in 25 cm2 flasks were washed in Hanks' balanced salt solution, without Ca21/Mg2+ (HBSS), fixed in 2.5% glutaraldehyde (EM grade) in phosphatebuffered saline (PBS) and scraped off the plastic using a cell scraper (Northumbria Biologicals). Trypsinised cells were also fixed in 2.5% glutaraldehyde for EM studies. Standard techniques were used for sample preparation.
Immunocytochemistry surface markers and intermediate filaments Monolayers of each cell line were prepared in eight-well slide chambers (Labtek) using appropriate growth medium. Monolayers were washed in HBSS and fixed in methanol containing 1% hydrogen peroxide. Non-specific binding sites were blocked with a 5 min preincubation in 20% FCS/HBSS. The following first antibodies were used: HMFG2 (Unipath) at 1 in 5 dilution; OC 125 (Cis UK) at I in 5 dilution (to determine CA 125 expression); vimentin at 1 in 15 dilution and pan-keratin at I in 15 dilution (both from Amersham), keratin-7 at 1 in 200 dilution (Sigma, clone LDS-68). Controls comprising either no antibodies or second antibody only were routinely included. Slide chambers were incubated with first antibodies for 60 min at 37°C, washed in PBS (3 x 5 min) and incubated for a further 60 min with goat anti-mouse peroxidase conjugate (Sera Lab. 1 in 175 dilution with 1 in 16 human serum). After washing in PBS (3 x 5 min), binding was visualised using diaminobenzidine tetrahydrochloride/ hydrogen peroxide. Washed slides were counterstained in haematoxylin, dehydrated through graded alcohols and xylene and mounted. The range of intensity of staining was scored on a scale of-to+ + + + and the approximate percentage of cells staining at either end of the range was also noted.
Results

Morphology
The appearance of the monolayers for the seven cell lines (excluding 41M) are shown in Figure 2a-h. As described previously (Wilson, 1984) OAW 42 was distinctive in forming hemicysts at confluence (Figure 2a ). OAW 28 (Figure 2b ) grew as small cells in tightly packed islands with well-defined margins, which eventually merged. 180D showed characteristic vacuolation at confluence (Figure 2c ). 200D showed a very distinctive appearance in early culture with threedimensional solid growth from subconfluent and confluent monolayers (Figure 2d ). This was maintained while cultures were subcultured using enzyme-free dissociation medium, but lost once harvesting with trypsin-versene was commenced. In later cultures the monolayer was made up of a heterogenously sized cell population with extensive multinucleation, grainy cytoplasm and some vacuolation ( Figure   2e ). Hemicysts were observed occasionally at confluence. The cells of 59M ( Figure 2f ) were more elongated but otherwise undistinctive even at confluence. 138D (Figure 2g Cytogenetic results All seven cell lines had complex karyotypes with multiple structural and numerical changes. Only one clone and/or its polyploidised version were present in each cell line. The modal chromosome numbers were near-tetraploid in cell lines OAW 42 and 180D, near-triploid in the lines 138D, 200D and 253D, hyperdiploid in the line 59M and the cell line OAW 28 had a hypodiploid modal chromosome number. Chromosomes 1, 3, 6, 7 and 11 seemed to be preferentially affected. The chromosome bands and regions most frequently rearranged were lpl3, 3pll-14, 3q13-21, 6plO-11 and 1lpl3-15. HSRs (homogeneously staining regions) were found in the cell line 180D. No DMs (double minutes) were observed in any of the cell lines. The complete karyotypic data are given in Table II 
Discussion
Details of seven cell lines established from seven patients diagnosed and treated for ovarian cancer have been presented here. Staining with HMFG2 confirmed that the cell lines were epithelial and the identification of desmosomes at ultrastructural level corroborated this. Expression of the antigenic determinant CA 125 is associated with >80% of nonmucinous epithelial tumours of the ovary (Kabawat et al., 1983) ; the expression of CA 125 by 6/7 of the cell lines together with the clinical and pathological details support the putative ovarian origin of these cell lines. Pathological confirmation of ovarian origin was absent for two of the lines, 180D and 253D. Although the patient from which 180D was derived was operated on for endometrial cancer 4 months before the date from which the ascites giving rise to 180D was obtained, the clinical history was not indicative of metastatic endometrial cancer. The presence of a tumour deposit on the bowel raised suspicions of metastatic bowel cancer, but expression of keratin-7 by 180D made this possibility unlikely since keratin-7 is not usually expressed by bowel tumours (Moll et al., 1982) . Since ovarian involvement could not be demonstrated for 253D it seems likely that this cell line is derived from a serous papillary carcinoma of the peritoneum, which is clinically similar to stage III ovarian carcinoma and responds similarly to chemotherapy (Fromm et al., 1990 ). 79 -84, -X, add (l)(pl3), add (l)(q21), + del(l)(p31), + add(l)(p32), -2,-2,-3, add (3)(pl3), -4,-4,-5,i(5)(qlO),del(5)(pl lpl3), del(8)(p21), -9,-9,i(9)(pO),-10,-I I,add (12)(q 12), + der (12)t(3; 12)(p21 ;q24),-13,-13, der(l4)t(5; 14)(q1 5;p13),-15,-15,-16, der (16)t(8; 16)(q I l;q 12),add(17)(q25),der(17)add (17)(p 1)add(17)(q25) ,-18, -20, der(20) add (20)(p13)add (20)(q 13),-21,-21, + der(?)t(?;3)(?q13), + 3 -8mar 83 -96,-X,-X,der(I)t(l; 1)(pl3;q13)add(l) (q42) x 2, + t(I;6)(qlO;plO), + der(3)t(3;15) (p 1 l;ql 1), + del(5)(pl 5),der(6)t(1;6)(pl 3;q25), + hsr(7)(p I1)add(7)(pl 1) x 2,del(7)(q21),-8,-8, i(8)(qI 0) x 2, + 9, + inv(l 2)(q13q24), + add(I 2)(p 12), -13,-14,der(14)t(3; 14)(q21 ;q24),-15,-15 add(l4)(q24) x 2,-17add(17)(pl 1),-19, add( l9)(q13),der(20)t(8;20;?)(q 1 ;p 13;?),-22,-22, +5 -8mar 52 -54,XX, + X, + 6, + i(6)(plO), + i(7)(qlO),-8, + add(I 1)(p13),-13,-13,der(13;14)(qlO;qlO), -16,-17, -18,add(19)(q13), + 7 -9mar 138D p12-14 66-72,-X,der(I)t(1;3)(p36;pl4),del (2)(p2l), der(2)t(2;2)(p25;q21),der(2)t(2;5)(q31;q22), del(3)(pl3),add(3)(pl3),-4, + 6, del(6) (ql3q23), + add(7)(pl 3),der(7)t(3;7)(p25;p22),-8,-9,-9, der(I I)t(l;l l)(p32;p15),-13,-14, + 15,-17,-17,-18, -18,-19,-21,-22, + der(?)t(?;3)(?;q 13), + 7 -13mar OAW 28 p12 40 -46,X,der(X)t(X;3)(q21;p12),-1, dic(2;?)(p23;?),-3del(3)(q21),-4, der(4)t(1;4)(ql l;pl6),-S,-S, der(6)t(3;6)(q12;pl 1),del(7)(ql 1),-8 + der(9)t(1;9) (pI13;qI13),der(10O)t(2; I10)(p I10;q I10),add(11)(q23), + add(I 1)(pl 5),-13,add(14)(pl 1),der(I5)t(l;1 5) (ql2;q22), -17,-17,-19,-20,-20,-21,-21,- 63 -69,-X,-X,der(X;5)(plO;plO), + add(l)(p13), + 2, -3,-5,i(6)(plO),add(6)(pl 1),add(6)(p21), + 7, + der(7)t(1 ;7)(p13;p 13)add(1)(p36),-8,add(8) (p1 1),-10,-12,add(12)(pl 1),-13,i (13) The epithelial cell lines showed malignant genotypes, as indicated by aneuploidy and a wide range of chromosomal abnormalities. The cytogenetic literature on ovarian carcinomas now comprises about 200 published cases with chromosome abnormalities (Mitelman, 1991) . Typically the tumour karyotypes are complex, with massive numerical and structural aberrations, and modal chromosome number in the hypodiploid or near-triploid range. The most prominent chromosome changes involve chromosome losses, deletions and unbalanced translocations, all leading to loss of chromosome material. The recurrent chromosome alterations have been recognised and localised to chromosome bands and regions: lp36, lq21-23, 3pl2-13, 6q21, llpl3-15, 19p13 and 19ql3 (Pejovic et al., 1992) . Our findings of multiple structural and numerical changes in seven ovarian carcinoma cell lines concur with the data in the literature. The presence of multiple changes precludes identification of the primary cytogenetic event in tumour development. However, the apparent frequency of structural changes of llp both in the literature (Ehlen and Dubeau, 1990; Eccles et al., 1992; Viel et al., 1992; Vanda nme et al., 1992) and in our seres (in four of the seven cell lines) indicate that these are particularly important in ovarian carcinoma pathogenesis. This interpretation is further strengthened by the same nature of the changes in all four cell lines as well as in most of the previous reports, namely the loss of material distal to lpl3-15. The data thus support the existence in llp of a tumoursuppressor gene, the loss of which is of pathogenic importance in ovarian carcinoma.
The pattern of chromosome 1 involvement, as well as the rearrangements of 3p, 6q and 19q in our series are similar to those already published on ovarian carcinoma. However, none of the seven cell lines carried 19p+ marker chromosomes or any of the anomalies affecting 19p13 which are reported to be very frequent in ovarian carcinomas (Pejovic et al., 1992; Sato et al., 1991) .
In conclusion, this panel of seven tumour cell lines reflects to some extent the clinical and biological diversity of ovarian cancer and possesses features which are relevant to areas of current research interest including karyotypic changes which are associated with ovarian cancer. The lines are available through ECACC, Porton Down and cell line nomenclature has now been modified for simplicity and consistency. The old names, new names and accession numbers are shown in Table IV. 
